- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
House Report Blames Strict FDA for Drug Scarcity
Overly stringent enforcement by health regulators has caused the majority of drug shortages in the United States, according to a new report from a Republican-led House of Representatives committee.
The House Committee on Oversight and Government Reform said U.S. Food and Drug Administration inspections have forced four top generic drugmakers to shut down 30 percent of their manufacturing capacity, throwing the nation's drug supply into disarray.
Responding to the report, the FDA said preventing drug shortages is a "top priority," and that it works with companies to address serious quality issues and minimize supply disruptions.
Source: Reuters
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More
